Literature DB >> 19923825

Early gastric cancer: clinical characteristics and results of surgery.

A Nieminen1, A Kokkola, J Ylä-Liedenpohja, J Louhimo, H Mustonen, P Puolakkainen.   

Abstract

BACKGROUND: Early gastric cancer (EGC) is associated with better prognosis than advanced cancer of the stomach. Unfortunately, EGC accounts for a minority of operated gastric cancers in Europe. The aim of this study was to evaluate the clinical characteristics of EGC and the outcome after surgery.
METHODS: The study group comprised 94 EGC patients having undergone surgery at Helsinki University Central Hospital between April 1983 and July 2007.
RESULTS: The overall 5-year survival rate of EGC patients was 92.4%. Tumor location in the upper part of the stomach and mixed histological type impaired the prognosis (p = 0.043 and 0.008, respectively). The probability of lymph node metastasis was significantly higher when the tumor infiltrated gastric submucosa rather than mucosa (p = 0.012). Existence of lymph node or distant metastases decreased the survival rates (both p < 0.001). Total gastrectomy, pancreatic resection, and extended D2 lymph node dissection increased the complication rate, but did not have effect on survival.
CONCLUSION: The overall prognosis of EGC is favorable. The survival rates of EGC decreased when the tumor was located in the upper part of the stomach or was of mixed histological type, or the patient had lymph node or distant metastasis. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19923825     DOI: 10.1159/000226765

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

Review 1.  Redefining early gastric cancer.

Authors:  Savio G Barreto; John A Windsor
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

2.  Self-expanding metal stents or nonstent endoscopic therapy: which is better for anastomotic leaks after total gastrectomy?

Authors:  Choong Nam Shim; Hyoung-Il Kim; Woo Jin Hyung; Sung Hoon Noh; Mi Kyung Song; Dae Ryong Kang; Jun Chul Park; Hyuk Lee; Sung Kwan Shin; Yong Chan Lee; Sang Kil Lee
Journal:  Surg Endosc       Date:  2013-10-10       Impact factor: 4.584

Review 3.  Treatment of early gastric cancer in the Western World.

Authors:  Elfriede Bollschweiler; Felix Berlth; Christoph Baltin; Stefan Mönig; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Improving the AJCC/TNM classification for use in early gastric cancer.

Authors:  Paolo G Gobbi; Lara Villano; Donatella Pozzoli; Manuela Bergonzi; Alessandro Vanoli; Francesca Tava; Paolo Dionigi; Gino Roberto Corazza
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

5.  Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations.

Authors:  Audrey H Choi; Rebecca A Nelson; Shaila J Merchant; Jae Y Kim; Joseph Chao; Joseph Kim
Journal:  Gastrointest Endosc       Date:  2015-11-10       Impact factor: 9.427

6.  Clinical significance of the pattern of lymph node metastasis depending on the location of gastric cancer.

Authors:  Ki Bin Han; You Jin Jang; Jong Han Kim; Sung Soo Park; Seong Heum Park; Seung Joo Kim; Young Jae Mok; Chong Suk Kim
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

7.  Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts.

Authors:  Fujian Ji; Xuanwen Liu; Yuanyu Wu; Xuedong Fang; Guomin Huang
Journal:  Drug Des Devel Ther       Date:  2015-10-19       Impact factor: 4.162

8.  Linked color imaging (LCI), a novel image-enhanced endoscopy technology, emphasizes the color of early gastric cancer.

Authors:  Hiromitsu Kanzaki; Ryuta Takenaka; Yoshiro Kawahara; Daisuke Kawai; Yuka Obayashi; Yuki Baba; Hiroyuki Sakae; Tatsuhiro Gotoda; Yoshiyasu Kono; Ko Miura; Masaya Iwamuro; Seiji Kawano; Takehiro Tanaka; Hiroyuki Okada
Journal:  Endosc Int Open       Date:  2017-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.